Jacobio Pharmaceuticals Group Co Ltd
HKEX:1167

Watchlist Manager
Jacobio Pharmaceuticals Group Co Ltd Logo
Jacobio Pharmaceuticals Group Co Ltd
HKEX:1167
Watchlist
Price: 1.24 HKD -3.88% Market Closed
Market Cap: 981.8m HKD
Have any thoughts about
Jacobio Pharmaceuticals Group Co Ltd?
Write Note

Income Statement

Earnings Waterfall
Jacobio Pharmaceuticals Group Co Ltd

Revenue
23.2m CNY
Cost of Revenue
-22.4m CNY
Gross Profit
801k CNY
Operating Expenses
-381.3m CNY
Operating Income
-380.5m CNY
Other Expenses
18.6m CNY
Net Income
-361.9m CNY

Income Statement
Jacobio Pharmaceuticals Group Co Ltd

Rotate your device to view
Income Statement
Currency: CNY
Dec-2020 Jun-2021 Dec-2021 Jun-2022 Dec-2022 Jun-2023 Dec-2023 Jun-2024
Revenue
Revenue
486
N/A
544
+12%
153
-72%
150
-2%
96
-36%
81
-15%
64
-22%
23
-63%
Gross Profit
Cost of Revenue
(44)
(97)
(140)
(133)
(83)
(75)
(60)
(22)
Gross Profit
442
N/A
447
+1%
13
-97%
17
+33%
13
-26%
6
-51%
3
-48%
1
-75%
Operating Income
Operating Expenses
(233)
(289)
(314)
(375)
(486)
(510)
(411)
(381)
Selling, General & Administrative
(53)
(59)
(44)
(49)
(42)
(43)
(45)
(44)
Research & Development
(181)
(231)
(277)
(336)
(441)
(468)
(364)
(350)
Depreciation & Amortization
(5)
(7)
(5)
0
(6)
0
(10)
0
Other Operating Expenses
7
7
11
9
2
1
8
13
Operating Income
209
N/A
157
-25%
(302)
N/A
(358)
-19%
(474)
-32%
(504)
-6%
(408)
+19%
(380)
+7%
Pre-Tax Income
Interest Income Expense
(28)
(35)
0
66
102
93
49
20
Non-Reccuring Items
0
0
0
0
0
0
1
0
Total Other Income
(1 695)
(962)
0
0
0
0
(0)
(2)
Pre-Tax Income
(1 514)
N/A
(839)
+45%
(301)
+64%
(292)
+3%
(372)
-27%
(410)
-10%
(359)
+12%
(362)
-1%
Net Income
Tax Provision
0
0
0
0
0
0
0
0
Income from Continuing Operations
(1 514)
(839)
(301)
(292)
(372)
(410)
(359)
(362)
Income to Minority Interest
0
0
0
0
0
0
0
0
Net Income (Common)
(1 514)
N/A
(839)
+45%
(301)
+64%
(292)
+3%
(372)
-27%
(410)
-10%
(359)
+12%
(362)
-1%
EPS (Diluted)
-1.99
N/A
-1.11
+44%
-0.4
+64%
-0.39
+3%
-0.49
-26%
-0.54
-10%
-0.46
+15%
-0.47
-2%

See Also

Discover More